NASDAQ · Drug Manufacturers - Specialty & Generic

Canopy Growth Corporation (CGC) Stock

$0.68 +1.58% NASDAQ: CGC Healthcare

Valuation

MetricValue
Price$0.68
Market Cap$285.89M
P/E Ratio-1.90
P/B Ratio0.78
P/S Ratio0.72
EPS (TTM)$0.00
52-Week High$2.38
52-Week Low$0.66
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-29.85%
ROA-21.43%
ROCE-16.01%
Gross Margin-43.49%
Operating Margin-43.49%
Net Margin-73.95%
Debt/Equity0.40
Current Ratio3.14

Annual Financials (USD)

Metric20222023202420252026
Revenue$476.0M$333.0M$297.0M$269.0M$285.0M
Operating Profit$-1.0B$-2.6B$-229.0M$-117.0M$-73.0M
Net Profit$-310.0M$-3.3B$-657.0M$-598.0M$-263.0M
EPS$-7.70$-70.70$-8.79$-5.53$-0.88
Op Margin-214.2%-789.3%-77.0%-43.5%-25.7%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$5.6B$2.4B$1.3B$918.0M$1.1B
Total Liabilities$2.0B$1.7B$800.0M$430.0M$421.0M
Cash$776.0M$668.0M$170.0M$114.0M$365.0M
Borrowings$1.6B$1.4B$668.0M$348.0M$279.0M

Latest News

Why Canopy Growth Corporation (CGC) Dipped More Than Broader Market Today Zacks · Jul 13, 2026 Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know Zacks · Jul 9, 2026 Is Canopy Growth Stock Finally Worth Buying After Losing 99% of Its Value? Motley Fool · Jul 8, 2026 Canopy Growth Corporation (CGC) Declines More Than Market: Some Information for Investors Zacks · Jul 7, 2026 Canopy Growth: Is Another Reverse Stock Split Inevitable? Motley Fool · Jul 7, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$-546.0M$-558.0M$-282.0M$-166.0M$-64.0M
Investing Cash Flow$183.0M$423.0M$238.0M$-59.0M$-27.0M
Financing Cash Flow$3.0M$-38.0M$-36.0M$-16.0M$-28.0M
Net Cash Flow$-379.0M$-99.0M$-507.0M$-56.0M$251.0M
Free Cash Flow$-594.0M$-568.0M$-286.0M$-177.0M$-70.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-5.10
FCF Yield-39.54%
Quick Ratio2.39
Interest Coverage-3.36
Return 1Y-22.64%
Return 3Y-77.09%
Return 5Y-99.51%

Ownership

Insiders Held0.25%
Institutions Held7.90%
Institutions Float Held7.92%
Institutional HolderSharesReport Date
Tidal Investments LLC8,479,8932026-03-31
Morgan Stanley1,969,6402026-03-31
Lazard Asset Management LLC1,807,9862026-03-31
Jane Street Group, LLC1,582,3122026-03-31
Goldman Sachs Group Inc1,263,6022026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACBAurora Cannabis Inc. $3.88 -2.27% -2.89 $245.64M 0.00%
ACRSAclaris Therapeutics, Inc. $3.75 -2.09% -8.88 $552.00M 0.00%
BIOABioAge Labs, Inc. $5.10 -7.78% -2.73 $192.01M 0.00%
CABACabaletta Bio, Inc. $1.47 -3.29% -1.27 $249.23M 0.00%
DHDefinitive Healthcare Corp. $1.08 +0.00% -0.62 $115.28M 0.00%

About Canopy Growth Corporation

Canopy Growth Corporation is led by CEO Luc Mongeau, employs 1,029 people, headquartered in CA, publicly traded since 2014.

Canopy Growth Corporation (CGC) stock trades at $0.68 with a market capitalization of $285.89M. The stock is valued at a negative price-to-earnings (P/E) ratio of -1.90, reflecting a net loss over the last twelve months, price-to-book of 0.78, price-to-sales of 0.72. Over the past 52 weeks the stock has ranged between $0.66 and $2.38, and currently trades 71.4% below its 52-week high.

On profitability, Canopy Growth Corporation generates a return on equity (ROE) of -29.85% (negative, reflecting a net loss), return on capital employed of -16.01%, an operating margin of -43.49%, a net profit margin of -73.95%.

Canopy Growth Corporation by the numbers, 2017–2026

Between 2017 and 2026 Canopy Growth Corporation reported revenue of $40.0M rising to $285.0M, a change of +612.5% across 10 years. Compounded, revenue has grown -12.2% a year over five years, -5.1% over three, 6.0% over the last twelve months. Net profit fell to $-263.0M.

Operating margin went from -35.3% in 2017 to -25.7% in 2026, a gain of 9.6 percentage points. The most recent net margin is -73.95%. On a trailing twelve-month basis to Jun '26, revenue is $321.0M and net profit $-260.0M.

Borrowings rose from $10.0M to $279.0M, cash from operations was $-64.0M in the latest year, positive in 0 of the last 10.

Return on equity has averaged -146.6% over five years, and was -37.7% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Canopy Growth Corporation (CGC) — frequently asked questions

What is Canopy Growth Corporation (CGC) stock price today?

Canopy Growth Corporation (CGC) is currently trading at $0.68, up 1.58% today.

What is CGC P/E ratio?

Canopy Growth Corporation's P/E ratio is -1.90. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is CGC return on equity (ROE)?

Canopy Growth Corporation's return on equity (ROE) is -29.85%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Canopy Growth Corporation's market cap?

Canopy Growth Corporation has a market capitalization of $285.89M.

Does CGC pay a dividend?

Canopy Growth Corporation is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does CGC carry?

Canopy Growth Corporation has a debt-to-equity ratio of 0.40. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is CGC's profit margin?

Canopy Growth Corporation reports a net profit margin of -73.95% — the share of revenue left after every cost, including tax and interest.

What sector is CGC in?

Canopy Growth Corporation is classified under Healthcare, in the Drug Manufacturers - Specialty & Generic industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is CGC listed on?

Canopy Growth Corporation trades on NASDAQ under the ticker CGC.

What is CGC's 52-week range?

Over the last year Canopy Growth Corporation has traded between $0.66 and $2.38.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens CGC currently matches

On the figures above, Canopy Growth Corporation passes the filters for 4 of our ready-made screens, among them Penny Stocks, Stocks Under $5, Stocks Under $1. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Penny StocksStocks Under $5Stocks Under $1Micro Cap Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.